Qualisure Diagnostics
About Qualisure Diagnostics
Qualisure Diagnostics Inc. develops molecular tests that enhance cancer care by identifying features that help oncologists to personalize treatments. Each of our biomarkers is designed to influence clinical decision-making and to facilitate Precision Medicine. Understanding which cancers are indolent or aggressive, and which ones are more likely to respond to certain treatments can guide an oncologist to recommend a treatment strategy that is optimized for each patient. Our precision diagnostics – discovered using our own machine learning algorithms – minimize the burden of cancer treatment by avoiding toxic and costly treatments that are unlikely to provide benefit.
Company Metrics
- Employees: 1-10
- Monthly Visits: 1723
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 1795000 CAD
- Last Funding: None (Seed)
- Funding Status: Seed
Technology Stack
Qualisure Diagnostics actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Health Diagnostics, Life Science, Medical
Headquarters: Calgary, Alberta, Canada
Leadership
- Oliver Bathe - CEO, Founder LinkedIn
Employees
- Dave Ehman - Chief Technology Officer (LinkedIn)